Navigation Links
New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
Date:5/27/2008

ncer means that the cancer has spread to other nodes and/or organs in the body.

About 150,000 new cases are detected each year in the United States. Over a lifetime, about 1 in 19 people develop colorectal cancer, and more than 49,960 people are expected to die from it in the U.S. this year. According to the American Cancer Society, colorectal cancer is the third leading cause of cancer-related death in the U.S., accounting for about 10% of all cancer deaths.

Please see accompanying full prescribing information, including BOXED WARNING, and visit http://www.eloxatin.com for more information about Eloxatin(R).

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cauti
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
2. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
3. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
4. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
5. ORTHO EVRA(R) Prescribing Information Updated
6. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
9. Initiation of Coverage Informational Review Issued by Scimitar Equity Research
10. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ABBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstCall/ ... ABT ) as one of its Most Admired Corporate Deal... honored Abbott as its Most Admired Dealmaker in ...e of acquisitions and divestitures since January 2...ed its business portfolio with a focus on high-gro...
(Date:11/19/2009)..., Part of International Internet Week of Action ...wswire/ -- The U.S. Food and Drug Administration t...nal effort, called the International Internet Week...s involving medical products. ,, (Logo: http:/..., During the effort, the FDA,s Office of Crimin...
(Date:11/19/2009)... PRINCETON, N.J., Nov. 19 Impliant...atives to traditional spinal fusion surgery, annou...cutive management team as the Vice President of Cl...ttp://www.newscom.com/cgi-bin/prnh/20080527/NETU06...cal and regulatory experience in the spinal and me...
Breaking Medicine Technology:The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 1Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3DST Health Solutions Achieves ISO 9001 3A2008 Certification 52954 1DST Health Solutions Achieves ISO 9001 3A2008 Certification 52954 2
... 2007-AstraZeneca today announced clinical,trial d...etiapine,fumarate sustained release), at the Europ...ta demonstrated that the SEROQUEL®,sustained r...release), administered once daily, significantly i...asured by PANSS) and increased the,time to psychia...
...NESS WIRE)--Mar 20, 2007 - MGI PHARMA, INC.,(NASDA...ncology and,acute care, today announced that a ran... 3 trial of Aquavan(R) (fospropofol,disodium) Inje...copy successfully met its primary endpoint of seda...mong patients who,received an initial bolus dose o...
Other Medicine Technology:Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 2MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 3MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 4MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 5MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 6
(Date:11/20/2009)...SHINGTON, Nov. 20 The ...s to modify health care reform legislation release... a health insurance individual coverage mandate. T...e mandate will minimize adverse selection stemming...cribed by the bill. ,, "The individual mandate ...
(Date:11/20/2009)...AGO, Nov. 20 The Americ...ood and Drug Administration (FDA) to establish app...cals. ,, Citing concern about the safety of wh...ut the benefit of professional consultation or exa...he application of chemically based tooth whitening...
(Date:11/20/2009)... NEW YORK, Nov. 20 SIRIU... it will broadcast Doctor Radio Reports: What E...depth special hosted by veteran journalist Perri P...n/prnh/20080819/NYTU044LOGO ) ,, Doctor Radio...mmograms will air November 21 live at 10:00 am ...
(Date:11/20/2009)... Based out of Dallas, TX, the new additi... products that are made in the USA. , ...-- blue sky scrubs is an independent medical scrub...sign, production and distribution of hospital unif...ing their products via their online boutique, the ...
(Date:11/20/2009)... Longtime OB/GYN warns against the new b...Preventative Services Task Force. These guidelines... of human lives. When is it wrong to be safe than ...ventative Services Task Force recommendations, pub...nal Medicine, has set off a firestorm in the medic...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3
... key molecule called 'P2X receptor' that control p... the development of painkillers for recurring migr... by a team of researchers including Dr Chris Thomp...ms to closely study the 'P2X receptors'. ...
... to be obsessed with the idea of shredding weight ...vealed that media reports about her being fat made... "It made me obsessed. I would beat myself up...ened after she crashed from 130 pounds in 2003 to ...
...alpha (ER-alpha), is a risk factor for breast canc...ancers lack detectable ER-alpha . These ER-al... worse prognosis than do ER-alphapositive breast c... issue of the Journal of Clinical Investigation, J...
...his year have eclipsed fatalities in 2006 as the c...isease in a decade , medical officials said Thursd... for the first half of this year out of 14,986 cas...ead, but it is a little bit better than before," h...
...ences has submitted an application with the Drug C...rtake phase-1 clinical trials of its new drug Suvn...Alzheimer's and schizophrenia. 'Treatment ...al needs,' said a statement by the firm. ...
... infection in Australia is back to the levels of 2...the death sentence it once was and homosexuals are...ected sex. A recent court case in Melbourn...ork. The Age newspaper claims to have in...
Other Medicine News:
Macroplastique Implantation System
...The Alpha I continues to be a proven, reliable pen...ve mechanical reliability rates of over 97.5% at f...contributes to excellent mechanical reliability ra...des maximum, controlled girth expansion to fill th...
Alpine Reusable Leg Bag - 26 oz. Capacity
Alpine Reusable Leg Bag - 15 oz. Capacity
Medicine Products: